Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 1 September 2024 31 August 2025 31 August 2025 13577208 Ms QIAOPING LIU iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13577208 2024-08-31 13577208 2025-08-31 13577208 2024-09-01 2025-08-31 13577208 frs-core:CurrentFinancialInstruments 2025-08-31 13577208 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13577208 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 13577208 frs-bus:Micro-entities 2024-09-01 2025-08-31 13577208 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 13577208 frs-bus:Director1 2024-09-01 2025-08-31
Registered number: 13577208
SHANGHAI HESICARE SCIENCE TECHNOLOGY (UK) LTD
Unaudited Financial Statements
For The Year Ended 31 August 2025
PRO TAX AND ACCOUNTING LTD
Balance Sheet
Registered number: 13577208
2025
£
Current assets 42,433
Creditors: Amounts Falling Due Within One Year (40,469 )
NET CURRENT ASSETS 1,964
TOTAL ASSETS LESS CURRENT LIABILITIES 1,964
NET ASSETS 1,964
CAPITAL AND RESERVES 1,964

Notes

1. General Information
SHANGHAI HESICARE SCIENCE TECHNOLOGY (UK) LTD is a private company, limited by shares, incorporated in England & Wales, registered number 13577208 . The registered office is 1 Hampton Close, London, SW20 0RY.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Ms QIAOPING LIU
Director
07/06/2026